Pharmaceutical Executive
CMS Signals Looming Sunshine Act Audits: How to Prepare
March 1, 2024
New guidance suggests that CMS may be ramping up Sunshine Act auditing activities, potentially resulting in monetary liability for noncompliant reporting entities.
After more than a decade of relative inactivity, the Centers for Medicare & Medicaid Services(CMS) has signaled that it may soon commence audits of reporting entities under the Sunshine Act.
Published by Pharmaceutical Executive on March 1, 2024, available at https://www.pharmexec.com/view/cms-signals-looming-sunshine-act-audits-how-to-prepare.
Contacts
Capabilities
Suggested News & Insights
Ninth Circuit Rejects $8.5M Award Of Attorneys’ Fees to FCA WhistleblowerApril 14, 2026Sidley Represents AIP in Its US$1.272 Billion Acquisition of Avanos MedicalApril 14, 2026DOJ Announces First FCA Settlement Resolving Title VII Discrimination AllegationsApril 13, 2026Sidley Represents Telix Pharmaceutical in US$2.1 Billion Partnering Agreement With RegeneronApril 13, 2026White House and DOJ Announce Sweeping New Anti-Fraud InitiativesApril 10, 2026The End of PPM 1.0: And the Emergence of a More Durable Model for InvestorsMarch 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory

